Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
It features thorough molecular simulations of the receptor within its native membrane environment, complemented by ensemble virtual screening that considers its conformational mobility. For dimeric or oligomeric receptors, the full functional complex is constructed, and tentative binding sites are determined on and between the subunits to cover the entire spectrum of potential mechanisms of action.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
O43508
UPID:
TNF12_HUMAN
Alternative names:
APO3 ligand; TNF-related weak inducer of apoptosis
Alternative UPACC:
O43508; Q8IZK7; Q8WUZ7
Background:
Tumor necrosis factor ligand superfamily member 12 (TNFSF12), also known as APO3 ligand or TNF-related weak inducer of apoptosis, plays a pivotal role in various cellular processes. It binds to FN14 and possibly TNRFSF12/APO3, mediating NF-kappa-B activation and promoting angiogenesis and endothelial cell proliferation. Additionally, it is involved in the induction of inflammatory cytokines and promotes IL8 secretion.
Therapeutic significance:
Understanding the role of Tumor necrosis factor ligand superfamily member 12 could open doors to potential therapeutic strategies. Its ability to mediate apoptosis, NF-kappa-B activation, and promote angiogenesis highlights its significance in inflammation and possibly cancer therapy.